Language selection

Search

Patent 2150462 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2150462
(54) English Title: SYRUP CONTAINING N-ACETYL-CYSTEINE
(54) French Title: SIROP CONTENANT DE LA N-ACETYLCYSTEINE
Status: Term Expired - Post Grant Beyond Limit
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61K 31/195 (2006.01)
  • A61K 09/00 (2006.01)
  • A61K 09/08 (2006.01)
  • A61K 47/38 (2006.01)
(72) Inventors :
  • STROPPOLO, FEDERICO (Switzerland)
  • BONADEO, DANIELE (Italy)
  • SAUDINO, ALESSANDRO (Switzerland)
  • GAZZANIGA, ANNIBALE (Italy)
(73) Owners :
  • ZAMBON GROUP S.P.A.
  • ZAMBON S.P.A.
(71) Applicants :
  • ZAMBON GROUP S.P.A. (Italy)
  • ZAMBON S.P.A. (Italy)
(74) Agent: RICHES, MCKENZIE & HERBERT LLP
(74) Associate agent:
(45) Issued: 2005-04-19
(86) PCT Filing Date: 1993-11-23
(87) Open to Public Inspection: 1994-06-09
Examination requested: 2000-09-20
Availability of licence: N/A
Dedicated to the Public: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/EP1993/003280
(87) International Publication Number: EP1993003280
(85) National Entry: 1995-05-29

(30) Application Priority Data:
Application No. Country/Territory Date
MI92A002758 (Italy) 1992-12-02

Abstracts

English Abstract


A syrup containing N-acetyl-cysteine, stable for at least two years having
pleasant taste and smell, consists of an aqueous solution of
NAC, a sweetening agent and a thickening agent. The solution can also contain
a flavouring agent and a preservative. The pH is between
and 8.


Claims

Note: Claims are shown in the official language in which they were submitted.


-7-
CLAIMS
1. A composition in the form of a syrup containing (each 100 ml):
- N-acetyl-cysteine ~~~~2 - 4.2 g/100ml
- a sweetening agent ~~~0.02 - 0.3 g/100ml
- a thickening agent selected among:
sodium carboxymethylcellulose and
hydroxypropylmethylcellulose or
mixtures thereof ~~~~0.1 - 4 g/100ml
and further
- water q.s. to 100 ml
pH being settled within the interval 5-8.
2. A composition according to claim 1, wherein said composition further
contains
a flavouring agent in an amount of (0.1 - 0.4 g/100ml).
3. A composition according to claim 1, wherein said composition further
contains
a preservative in an amount of (0.05 - 0.5 g/100ml).
4. A composition according to claim 1, wherein said composition further
contains
a flavouring agent in the amount of (0.1 - 0.4 g/100ml) and a preservative in
the amount of
(0.05 - 0.5 g/100ml).
5. A composition according to claim 3 or claim 4, wherein said preservative is
selected from the group consisting of sodium edetate, sodium benzoate, methyl
4-
hydroxybenzoate, propyl 4-hydroxybenzoate and mixtures thereof.

-8-
6. A composition according to any one of claims 1 to 5, wherein said
sweetening
agent is selected from the group consisting of saccharin, sodium saccharin,
and cyclamates or
mixtures thereof.
7. A composition according to any one of claims 1 to 6, wherein the pH is
between
6.5 and 7.

Description

Note: Descriptions are shown in the official language in which they were submitted.


WO 94/12168 PCT/EP93/03280
SYRUP CONTAINING N-ACETYL-CYSTEINE
The present invention relates to a composition in the form of a
syrup containing N-acetyl-cysteine as active ingredient.
N-acetyl-cysteine (hereinafter briefly referred to as NAC) is a
pharmacological properties,
compound endowed with several useful
making it a widely used drug.
In the treatment of cold diseases, NAC showed to be useful thanks to
its mucolytic properties.
One of the pharmaceutical forms largely used in the therapy of cold
diseases is syrup, particularly suitable also for pediatric use.
NAC is available in several pharmaceutical forms, however the high
reactivity of the molecule, the relative instability and the
characteristic sulphureous smell and taste make extremely
troublesome the achievement of liquid forms for oral use which are
time-stable and with a good palatability.
The preparation of a syrup provides, practically in ail the cases,
the use of a disaccharide (sucrose) or of a simple sugar as a
sweetening and thickening agent of the aqueous solution of the drug.
However, the interaction of NAC with sugars gives to the solution an
unacceptable brown colouring and the titre of NAC decreases.
Thus, it is not possible to leave NAC in solution for a long time in
the presence of sucrose.
Similarly, the reactions giving brown colour and causing bad smell
take place also between NAC and the monosaccharides whose use is
described in the French patent application No. 2631831 in the name
of Calco Anstalt.
' As far,as we know, the only syrup formulation containing NAC on the
market consists in a composition to be prepared at the moment of use
by dissolution in water of a granulate.
After preparation, the extemporaneous syrup must be used within 3

WO 94/12168 PCT/EP93/03280
- 2 -
x
weeks. '
We have now surprisingly found that it is possible to prepare a
time-stable NAC syrup having a pleasant taste without using sugars.
Therefore, object of the present invention is a composition in the
form of a syrup containing (each 100 ml>:
- N-acetyl-cysteine 2 -4.2 g/100 mi
- a sweetening agent 0.02-0.3 g/100 ml
- a thickening agent selected among:
sodium carboxymethylcellulose and
hydroxypropylmethylcellulose or
mixtures thereof 0.1 -4 g/100 mI
and optionally:
- a flavouring agent 0.1 -0.4 g/100 mi
~5 - a preservative 0.05-0.5 g/100 ml
and further
- water q.s. to 10o ml
pH being settled within the interval 5-8. .
The above solution results to be stable in a closed bottle under
inert gas for at least 2 years under environmental conditions. When
the bottle is opened, the solution shows to have a pleasant taste
and to be free from bad smells; NAC maintains the initial titre and
the open syrup results to be stable for at least 5 weeks.
For sweetening agent we mean a substance able to give a sweet taste
to the solution but wick does not contain sugars. Specific examples
of sweetening agents are saccharin, sodium saccharin and cyclamates
or mixtures thereof.
The amount of sweetening agent will be the minimum amount sufficient
to give a pleasant taste to the solution.
The thickening agent is selected among sodium carboxymethyicelluiose

O 94/12168 ~ ~ ~ PCTIEP93/03280
- 3 -
methylcellulose and hydroxypropylmethyleellulose or mixtures
thereof. Surprisingly, these substances showed to be compatible with
NAC and to be able to give to the solution a thickness suitable for
the usual palatability of a syrup.
To these three base components cNAC, sweetening agent and thickening
agent) water can~be added up to the selected volume, by optionally
rectifying the resultant pH so that it is maintained within the
interval from 5 to 8. Preferably, pH will be from b.5 to 7.
The syrup could also, but not necessarily, contain a flavouring
agent in order to improve the palatability, especially for pediatric
use.
Since the syrup is generally manufactured in absence of asepsis,
pharmacopoeiae require the compulsory presence of a preservative.
The preservative is further required to assure the microbioiogicai
quality during the time of use by the patient.
In this case, preservatives selected among sodium benzoate, methyl
4-hydroxybenzoate, propyl 4-hydroxybenzoate and mixtures thereof
will be preferably used.
With the double function of preservative and of metal cheiating
agent also sodium EDTA could be used in addition to or in partial
substitution of the above preservatives.
The preparation of the syrup according to the present invention is
carried out under inert gas by simple dissolution of the substances
in the predetermined amount of water.
The resultant solution is shared into multidose bottles or in
single-dose containers.
The packaging of multi-dose bottles could provide the contemporaneous
supplying of a graduated measure for the correct dosage of the
single doses for grown-up people (for example 10 ml> or for children

WO 94/12168 PCT/EP93/03280
- 4 -
(for example 5 ml).
In order to better illustrate the present invention the following
examples are now given.
Example 1
f
liters of a syrup containing teach 100 ml>:
NAC 2.1 g
Saccharin 0.04 g
Sodium carboxymethylcellulose 0.2 g
10 Sodium benzoate 0.15 g
Sodium edetate 0.1 g
Raspberry flavour 0.25 g
Water q.s. to 100 ml
were prepared by simple dissolution of the substancespurified
in
and de-aerated water under nitrogen atmosphere.
The pH of the resultant solution was rectified
to the correct vdiue
6.5 by addition of sodium hydroxide.
The solution was shared at the rate of 150 ml/bottle.
The bottles were stored for 2 years at room temperature.
After this period, the titre of NAC resulted to than 95i
be higher
of the initial one.
Such a titre resulted to be higher than 90r, of one also
the initial
after 5 weeks from the opening of the bottle.
The syrup, also after 2 years of storage, showed pleasant
to have a
taste and smell and a good general palatability.
Example 2
10 1 of a syrup having the following composition mi>:
(each 100
NAC 2.1 g
Sodium saccharin 0.04 g
Hydroxypropylmethylcellulose 0.2 g

O 94/12168 , ~ PCT/EP93/03280
- 5 -
Methyl 4-hydroxybenzoate 0.1 g
Sodium edetate 0.1 g
Apricot flavour 0.1 g
Water q.s. to 100 ml
were prepared by dispersion of hydroxypropylmethylceilulose in a
part of boiling water which was cooled to room temperature. After
hydration of hydroxypropylmethylcellulose, it was poured into a
solution obtained by dissolving all the remaining substances in
purified and de-aerated water, under nitrogen atmosphere.
The pH of the solution was rectified to pH b,5 with sodium
hydroxide.
The solution was shared into single-dose sachets of 10 mi each
containing about 200 mg of NAC.
~5 Example 3
10 1 of a syrup having the following composition (each 100 mi>:
NAC 2.1 g
Sodium saccharin 0.04 g
Hydroxypropylmethylcellulose 0.2 g
Sodium edetate o.1 g
Apricot flavour 0.1 g
Water q.s. to 100 ml
were prepared by dispersion of hydroxypropylmethylcellulose in a
part of boiling water which was cooled to room temperature. After
hydration of hydroxypropylmethylcellulose, it was poured into a
solution obtained by dissolving all the remaining substances in
' purified and de-aerated water, under nitrogen atmosphere.
The pH of the solution was rectified to pH b.5 with sodium
hydroxide.
The solution was shared into single-dose glass vials of 10 mi with

WO 94/12168 PCT/EP93/03280
- 6 -
rubber stopper each containing about 200 mg of NAC.
Example 4
By working as described in Example 1, 10 1 of syrup having the
following composition (each 100 ml> were prepared: ,
4.2 g
NAC
Sodium saccharin 0~08 g
Sodium carboxymethylcelluiose 0.20 g
Sodium benzoate 0.15 g
Sodium edetate 0.10 g
Raspberry flavour 0.4 g
Water q.s. to 100 ml
The pH of the solution was rectified to pH 6.5 with sodium
hydroxide.
The solution was shared into bottles at the rate of 150 ml each
bottle.
Example 5
By working as described in Example 2, 10 1 of syrup having the
following composition (each 100 ml) were prepared:
20 NAC 2.1o g
Saccharin 0.04 g
Hydroxypropylmethylcellulose 0.40 g
Methyl 4-hydroxybenzoate 0.10 g
Banana flavour 0.4 g
25 Water q.s. to 100 ml
G
The pH of the solution was rectified to pH 7 with sodium hydroxide.
The solution was shared into bottles at the rate of 450 mI each '
bottle.

Representative Drawing

Sorry, the representative drawing for patent document number 2150462 was not found.

Administrative Status

2024-08-01:As part of the Next Generation Patents (NGP) transition, the Canadian Patents Database (CPD) now contains a more detailed Event History, which replicates the Event Log of our new back-office solution.

Please note that "Inactive:" events refers to events no longer in use in our new back-office solution.

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Event History , Maintenance Fee  and Payment History  should be consulted.

Event History

Description Date
Inactive: Expired (new Act pat) 2013-11-23
Letter Sent 2007-07-30
Inactive: IPC from MCD 2006-03-11
Grant by Issuance 2005-04-19
Inactive: Cover page published 2005-04-18
Inactive: Applicant deleted 2005-04-12
Pre-grant 2005-02-01
Inactive: Final fee received 2005-02-01
Notice of Allowance is Issued 2004-09-13
Notice of Allowance is Issued 2004-09-13
Letter Sent 2004-09-13
Inactive: Approved for allowance (AFA) 2004-08-12
Amendment Received - Voluntary Amendment 2003-10-30
Inactive: S.30(2) Rules - Examiner requisition 2003-07-07
Amendment Received - Voluntary Amendment 2000-11-30
Inactive: Application prosecuted on TS as of Log entry date 2000-10-18
Letter Sent 2000-10-18
Inactive: Status info is complete as of Log entry date 2000-10-18
Request for Examination Requirements Determined Compliant 2000-09-20
All Requirements for Examination Determined Compliant 2000-09-20
Application Published (Open to Public Inspection) 1994-06-09

Abandonment History

There is no abandonment history.

Maintenance Fee

The last payment was received on 2004-10-28

Note : If the full payment has not been received on or before the date indicated, a further fee may be required which may be one of the following

  • the reinstatement fee;
  • the late payment fee; or
  • additional fee to reverse deemed expiry.

Patent fees are adjusted on the 1st of January every year. The amounts above are the current amounts if received by December 31 of the current year.
Please refer to the CIPO Patent Fees web page to see all current fee amounts.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ZAMBON GROUP S.P.A.
ZAMBON S.P.A.
Past Owners on Record
ALESSANDRO SAUDINO
ANNIBALE GAZZANIGA
DANIELE BONADEO
FEDERICO STROPPOLO
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Claims 2003-10-29 2 32
Abstract 1994-06-08 1 36
Description 1994-06-08 6 195
Claims 1994-06-08 1 21
Reminder - Request for Examination 2000-07-24 1 116
Acknowledgement of Request for Examination 2000-10-17 1 178
Commissioner's Notice - Application Found Allowable 2004-09-12 1 160
PCT 1995-05-28 9 290
Fees 2003-10-07 1 36
Fees 1998-10-06 1 34
Fees 2000-09-25 1 37
Fees 2002-10-02 1 38
Fees 2001-10-11 1 41
Fees 1997-10-20 1 43
Fees 1999-10-14 1 36
Correspondence 2005-01-31 1 34
Fees 1996-09-25 1 46
Fees 1995-05-28 1 53